https://www.selleckchem.com/products/CP-690550.html 27, 95% CrI, 1.08-1.11) vs diffuse subtype (TR 1.17, 95% CrI, 1.09-1.24) and the probability of increasing OS > 15% was 90% vs 67% in each subtype, respectively. The effect dwindles over time, which can be attributed to pathological changes and clinical practice changes. Our study confirms the effect of DPF is highly dependent on several clinical-pathological variables, with discreet and gradually declining benefit over platinum doublets in later years, at the expense of increased toxicity. These results may help to underpin the idea that external validity of AGC trials should be revised regularly. Our study confirms the effect of DPF is highly dependent on several clinical-pathological variables, with discreet and gradually declining benefit over platinum doublets in later years, at the expense of increased toxicity. These results may help to underpin the idea that external validity of AGC trials should be revised regularly.The present study aimed to investigate the application of graphene oxide (GO) as adsorbent material for the removal of atrazine (ATZ). The material produced was characterized to investigate the characteristics and applied as an adsorbent. The material obtained after the synthesis process presented oxygenated functional groups, which contributed to the development of a good adsorbent material. Studies were carried out to verify the influence of adsorbent material mass and initial pH of ATZ solution in adsorption capacity. Kinetic study determined that pseudo-second-order model best describes adsorbate-adsorbent interaction, with equilibrium time of 72 h. The effect of temperature on the material adsorption capacity was also studied. The Langmuir isotherm is the best fit to describe adsorption process GO-ATZ and maximum adsorption capacity obtained was 23.844 ± 0.694 mg g-1, at 318 K. Variations in process energies were determined, being a spontaneous adsorption, endothermic and characteristic of